Healthcare and disaster supply chain have becoming a more important and popular
research issues recently. However, only a few of paper is known about the current issues …

Decentralized or “redistributed” manufacturing has the potential to revolutionize the
manufacturing approach for cell and gene therapies (CGTs), moving away from the “Fordist” …

Cell and gene therapies have demonstrated excellent clinical results across a range of
indications with chimeric antigen receptor (CAR)–T cell therapies among the first to reach …

Background aims Decentralized, or distributed, manufacturing that takes place close to the
point of care has been a manufacturing paradigm of heightened interest within the cell …

Background The cell and gene therapy (CGT) field is at a critical juncture. Clinical successes
have underpinned the requirement for developing manufacturing capacity suited to patient …

Advanced therapy medicinal products (ATMPs), such as somatic cell-therapy medicinal
products or tissue-engineered products for human use, offer new and potentially curative …

Quality of medical and pharmaceutical products has a key role in healthcare systems such
as hospitals for better services to patients. This study proposes a comprehensive multi …

Introduction: Currently, promising outcomes from clinical trials of allogeneic cells, especially
allogeneic mesenchymal stromal cells, fibroblasts, keratinocytes, and human cardiac stem …

In the last decade, the advancement of stem cell research as a new therapeutic approach in
the field of tissue engineering, regenerative medicine, cell and gene therapy had urged …

Hematopoietic stem cell transplantation is a usual treatment used against cancers and blood
diseases. To diminish the incidence and severity of graft-versus-host disease, donors and …